Table 5.

Characteristics of patients with NHL in the pre- and post-HAART eras

Pre-HAART
1986-95
Post-HAART
1996-99
χ2Pvalue
New cases NHL 99 51  
Prior AIDS 57% 34%  .007    
Stage I 31% 14%  .0665-150   
Stage II 6% 10%  
Stage III 4% 8%  
Stage IV 59% 68%  
B symptoms 75% 85%  .180    
Bone marrow involvement 19% 22%  .730   
ECOG > 2 50% 42%  .278    
CD4 < 100 cells/mm3 73% 37% <.001    
CD4 median (range) cells/mm3 38 (2-763) 130 (2-636)  .00215-151 
Mean age at NHL (y) 37.9 (SD = 8.3) 43.9 (SD = 9.0)  .00015-152 
Pre-HAART
1986-95
Post-HAART
1996-99
χ2Pvalue
New cases NHL 99 51  
Prior AIDS 57% 34%  .007    
Stage I 31% 14%  .0665-150   
Stage II 6% 10%  
Stage III 4% 8%  
Stage IV 59% 68%  
B symptoms 75% 85%  .180    
Bone marrow involvement 19% 22%  .730   
ECOG > 2 50% 42%  .278    
CD4 < 100 cells/mm3 73% 37% <.001    
CD4 median (range) cells/mm3 38 (2-763) 130 (2-636)  .00215-151 
Mean age at NHL (y) 37.9 (SD = 8.3) 43.9 (SD = 9.0)  .00015-152 

Abbreviations explained in Table 3.

F5-150

χ2 for linear trend.

F5-151

P value by Mann-Whitney U test of statistics.

F5-152

P value by unpaired t test of statistics.

Close Modal

or Create an Account

Close Modal
Close Modal